Tenderwize
Back to tender search

Discount Agreement for Choriongonadotropin alfa

Techniker Krankenkasse·Hamburg, Germany·Deadline May 30, 2027 · 285 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2025-10 - Choriongonadotropin alfa

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No estimated value or framework maximum is provided. Bidders cannot assess potential revenue or pricing strategy.

Since all qualified applicants can participate, many competitors may join, potentially limiting market share for each c...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing Choriongonadotropin alfa to patients insured by TK, HEK, and hkk.
  • Conclusion of a discount agreement under § 130a Abs. 8 SGB V with uniform terms for all participating pharmaceutical entrepreneurs.
Show full summary

This is an Open House procedure by Techniker Krankenkasse (TK) and associated health insurers for discount agreements on the active substance Choriongonadotropin alfa. The contract is open to all qualified pharmaceutical entrepreneurs under uniform terms, with no exclusivity. The maximum contract duration is 24 months from June 1, 2025 to May 31, 2027. Submissions can be made at any time during the period, but must be submitted via email with qualified electronic signature or by post. The estimated contract value is not provided. The notice clarifies this is not a public procurement procedure under EU directives; legal challenges fall under social courts.

Risks

No estimated value or framework maximum is provided. Bidders cannot assess potential revenue or pricing strategy.

Since all qualified applicants can participate, many competitors may join, potentially limiting market share for each c...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur within the meaning of § 4 Abs. 18 AMG for the offered medicinal product.
  • Must have a registered office in Germany, another EU member state, or a EEA state (§ 9 Abs. 2 Satz 1 AMG).
  • Must hold a valid marketing authorisation for the relevant medicinal product or be otherwise entitled to place it on the market.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; contracts are offered to all qualified pharma entrepreneurs.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Discount Agreement for Choriongonadotropin alfa

Open House procedure for concluding discount agreements with all suitable pharmaceutical entrepreneurs for the active substance Choriongonadotropin alfa. Uniform terms apply; no exclusivity is granted.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Award Criteria

No award criteria; contracts are offered to all qualified pharma entrepreneurs.

Deadline

Deadline May 30, 2027

Procurement Details

Publication date
22 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
262953-2025

Documents (1)

Similar tenders